Freiburg, Germany

Regina Moog

USPTO Granted Patents = 3 



Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Regina Moog: Innovator in Pharmaceutical Chemistry

Introduction

Regina Moog is a notable inventor based in Freiburg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. Her work primarily focuses on the development of innovative solid forms of pharmaceutical compounds.

Latest Patents

Regina Moog's latest patents include advancements related to the compound 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine. One of her inventions pertains to mono-sulfate and hemi-sulfate salts of this compound, detailing their crystalline and amorphous forms and their applications in pharmaceutical formulations. Another patent focuses on the mono-sulfate salt, including crystalline forms A and B, an amorphous form, and various hemi-sulfate salts of the same compound.

Career Highlights

Throughout her career, Regina Moog has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her expertise in the field has allowed her to contribute to significant advancements in drug formulation and development.

Collaborations

Regina has collaborated with esteemed colleagues such as Olaf Grassmann and Franziska E. Rohrer, enhancing her research and innovation efforts in pharmaceutical chemistry.

Conclusion

Regina Moog's contributions to the field of pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the development of effective pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…